Premium
Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma
Author(s) -
Guidez Stephanie,
LacotteThierry Laurence,
Tomowiak Cecile,
Princet Isabelle,
Dreyfus Brigitte,
Olivier Gaelle,
Fleck Emmanuel,
Corby Anne,
Motard Carine,
Barrier Jocelyn,
Machet Antoine,
Le Dû Katell,
DebiaisDelpech Celine,
Chabin Michele,
Leleu Xavier,
Guilhot Joëlle,
Delwail Vincent
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16056
Subject(s) - medicine , idarubicin , regimen , rituximab , diffuse large b cell lymphoma , vincristine , prednisolone , cyclophosphamide , etoposide , mucositis , gastroenterology , chemotherapy , chop , pharmacology , lymphoma , surgery , cytarabine
reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. Blood, 133, 137–146. Liang, R. (2009) How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation. Blood, 113, 3147–3153. Loomba, R. & Liang, T.J. (2017) Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies, and future directions. Gastroenterology, 152, 1297–1309. Nakasone, H., Kurosawa, S., Yakushijin, K., Taniguchi, S., Murata, M., Ikegame, K., Kobayashi, T., Eto, T., Miyamura, K., Sakamaki, H., Morishima, Y., Nagamura, T., Suzuki, R. & Fukuda, T. (2013) Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation. American Journal of Hematology, 88, 477–484. Ramos, C.A., Saliba, R.M., de Padua, L., Khorshid, O., Shpall, E.J., Giralt, S., Patah, P.A., Hosing, C.M., Popat, U.R., Rondon, G., Khouri, I.F., Nieto, Y.L., Champlin, R.E. & de Lima, M. (2009) Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica, 94, 249–257. Varma, A., Saliba, R.M., Torres, H.A., Afrough, A., Hosing, C., Khouri, I.F., Nieto, Y., Shah, N.D., Parmar, S., Bashir, Q., Ahmed, S., Jones, R.B., Kebriaei, P., Olson, A.L., Shpall, E.J., Alousi, A.M., Qazilbash, M.H., Champlin, R.E. & Popat, U. (2016) Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation. Bone Marrow Transplantation, 51, 999–1001.